Several previous studies have investigated the role of lumican in tumor biology, for example downregulation of lumican was shown to accelerate lung cancer cell invasion through the p120 catenin pathway [25] and in stage II and III colon cancer patients high expression of lumican in tumor tissues was associated with good clinical outcome [26]. This evidence concerns the gene CTNND1 and malignant colon neoplasm.